Sugisawa Chiho, Okada Yosuke, Arao Tadashi, Mori Hiroko, Nishida Keiko, Isobe Kazumasa, Takekoshi Kazuhiro, Tanaka Yoshiya
The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.
Intern Med. 2013;52(2):281-4. doi: 10.2169/internalmedicine.52.8223. Epub 2013 Jan 15.
It is insufficient to distinguish benign tumors from malignant pheochromocytoma using histological analyses of resected tissue alone. We experienced an 18-year-old woman who complained of severe headaches in whom hypertension was revealed. She was suspected of having a malignant tumor based on her clinical characteristics, despite showing no evidence of metastatic lesions. The patient was diagnosed with an aggressive form of hereditary pheochromocytoma-paraganglioma syndrome (HPPS) based on immunohistochemical analyses and genetic testing. The present case indicates that conducting genetic testing, including SDHB mutation analyses, is required to determine the prognosis in patients highly suspected of having HPPS.
仅通过对切除组织进行组织学分析来区分良性肿瘤和恶性嗜铬细胞瘤是不够的。我们接诊了一名18岁女性,她主诉严重头痛,检查发现患有高血压。尽管没有转移病灶的证据,但根据其临床特征怀疑她患有恶性肿瘤。基于免疫组化分析和基因检测,该患者被诊断为侵袭性遗传性嗜铬细胞瘤-副神经节瘤综合征(HPPS)。本病例表明,对于高度怀疑患有HPPS的患者,需要进行包括SDHB突变分析在内的基因检测以确定预后。